Head And Neck Squamous Cell Carcinoma (hnscc) - Cancer Science

Relevant Publications

Nuclear miR-451a activates KDM7A and leads to cetuximab resistance in head and neck squamous cell carcinoma.

Issue Release: 2024

Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma.

Issue Release: 2024

Prognostic Value of the F-FDG PET/CT and Haematological Parameters in Head and Neck Cancer.

Issue Release: 2024

Dynamic change of gut microbiota in head and neck concurrent chemoradiotherapy patients and its potential value in the prediction of acute oral mucositis grade as well as quality of life.

Issue Release: 2024

Ramucirumab in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma: a single-centre, phase 1/2 trial.

Issue Release: 2024

The Notch inhibitor, FLI-06, increases the chemosensitivity of head and neck Squamous cell carcinoma cells to taxanes-based treatment.

Issue Release: 2024

Predictive capacity for local disease control of neogenin-1 (NEO1) transcriptional expression in patients with head and neck squamous cell carcinoma.

Issue Release: 2024

Increased Immune Infiltration and Improved Prognosis of Head and Neck Squamous Cell Carcinoma Associated with Reduced Ancient Ubiquitous Protein 1 Gene Expression.

Issue Release: 2024

CTHRC1 is a prognostic biomarker correlated with immune infiltration in head and neck squamous cell carcinoma.

Issue Release: 2024

Integrative machine learning and neural networks for identifying PANoptosis-related lncRNA molecular subtypes and constructing a predictive model for head and neck squamous cell carcinoma.

Issue Release: 2024

Perineural invasion is associated with function-evoked pain and altered extracellular matrix in patients with head and neck squamous cell carcinoma.

Issue Release: 2024

Clinicopathological Factors as Predictors for Establishment of Patient Derived Head and Neck Squamous Cell Carcinoma Organoids.

Issue Release: 2024

FGD-PET/CT three months after (chemo)radiotherapy for head and neck squamous cell carcinoma spares considerable number of patients from a salvage neck dissection.

Issue Release: 2024

Obesity and Survival After Immune Checkpoint Inhibition for Head and Neck Squamous Cell Carcinoma.

Issue Release: 2024

Dihydroartemisinin inhibits HNSCC invasion and migration by controlling miR-195-5p expression.

Issue Release: 2024

Surgical margins in head and neck squamous cell carcinoma: A narrative review.

Issue Release: 2024

Small extracellular vesicles in plasma carry luminal cytokines that remain undetectable by antibody-based assays in cancer patients and healthy donors.

Issue Release: 2024

Audiological Outcomes of Weekly vs. Triweekly Cisplatin in Head and Neck Cancer with Cochlear-Sparing Intensity-Modulated Radiation Therapy.

Issue Release: 2024

Reirradiation in head and neck squamous cell carcinoma; prognostic indicators, oncologic and functional outcomes.

Issue Release: 2024

Head and neck squamous cell carcinoma (HNSCC) in solid organ transplant recipients - Results from the scientific registry of transplant recipients (SRTR) database.

Issue Release: 2024

What role do biomarkers play in cancer treatment?

How Do Blister Packs Benefit Cancer Patients?

How to Prepare for Bone Marrow Aspiration?

What are the Benefits of Telemedicine in Cancer Care?

Which Types of Cancer Are Most Commonly Associated with Dysphagia?

How do Keratins Affect Tumor Behavior?

Which Cancers are Associated with MSI-H?

What are the Challenges in Using Natural Compounds for Cancer Treatment?

How is Processed Meat Linked to Cancer?

Why is Tumor Location Important in Cancer?

Head And Neck Squamous Cell Carcinoma (hnscc) - Cancer Science

Relevant Publications

Partnered Content Networks

Relevant Topics